Cristina Might, Founder and Executive Director of NGLY1.org, shared her story and perspective at the recent Federation of American Societies for Experimental Biology (FASEB) at a Capitol Hill briefing this month in Washington, D.C. This briefing focused on rare disease research and the critical role the National Institutes of Health (NIH) plays in supporting discovery.
During this presentation, Cristina, along with fellow speakers Hudson Freeze, PhD, FASEB President and Director of the Human Genetics Program at the Sanford Burnham Prebys Medical Discovery Institute and Hilary Vernon, MD, PhD, Assistant Professor of Pediatrics at the Johns Hopkins University School of Medicine emphasized how new therapies and treatments would not be possible without the fundamental scientific knowledge gained through basic research.
Continued discussion involved the future of rare disease research and how further advances will be made possible through the cooperation of scientists, clinicians, and patient advocates.
For more information on this meeting, click here.